文献速递消化道肿瘤与早癌

MSH3及可能MLH3胚系杂合突变作为经典抑癌基因增加结直肠癌风险

Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.
PubMed 文献 · Gut · 2026-09-11

BACKGROUND: MSH3 and MLH3 are non-canonical DNA mismatch repair genes, involved in repairing insertion-deletion mutations.…

要点

  • MSH3和MLH3胚系杂合突变增加结直肠癌风险,分别约2.2倍和1.6倍。
  • 肿瘤呈微卫星稳定但超突变,≥2bp缺失增加约12倍,常伴ID4特征。
  • 无二次打击的杂合子结直肠癌无超突变,提示不完全外显。

核心结论

  • MSH3和MLH3胚系杂合突变作为经典抑癌基因,通过超突变增加结直肠癌风险,表型类似PMS2突变林奇综合征。
  • 双等位基因MSH3或MLH3突变携带者表型类似部分cMMRd患者。

主要发现

  • 一例结直肠癌/多发息肉病例携带双等位基因MSH3突变,另一例携带双等位基因MLH3突变。
  • MSH3和MLH3胚系杂合子结直肠癌风险分别增加2.2倍(p=6.6×10-5)和1.6倍(p=0.028),源于体细胞二次打击使野生型等位基因失活。
  • 所有MSH3或MLH3缺陷的结直肠癌均为微卫星稳定但超突变,≥2bp缺失尤其增加约12倍,ID4特征通常存在(p<0.0001)。
  • 无二次打击的杂合子结直肠癌无超突变。

关键数值与推荐

  • MSH3杂合突变结直肠癌风险增加2.2倍(p=6.6×10-5),MLH3杂合突变增加1.6倍(p=0.028)。
  • MSH3或MLH3缺陷肿瘤中≥2bp缺失增加约12倍,ID4特征通常存在(p<0.0001)。

临床怎么用

  • 对结直肠癌或多发息肉患者考虑MSH3和MLH3胚系检测,尤其微卫星稳定但超突变肿瘤。
  • 识别ID4特征可能提示MSH3或MLH3缺陷,辅助遗传评估。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: MSH3 and MLH3 are non-canonical DNA mismatch repair genes, involved in repairing insertion-deletion mutations. Colorectal cancer (CRC) and adenomas have been reported in patients with bi-allelic germline MSH3 mutations, and in a very few bi-allelic MLH3 mutation carriers. OBJECTIVES: We hypothesised that germline loss-of-function MSH3 and MLH3 mutations were akin to constitutional mismatch repair deficiency (cMMRd) and Lynch syndrome, such that CRC could result from either bi-allelic germline mutations or heterozygous germline mutations after second hits. DESIGN: About 12 000 CRC and multiple polyp cases and 460 000 controls were studied. 2023 patients underwent cancer genome sequencing. RESULTS: One CRC/multiple polyp case had bi-allelic MSH3 mutations and another, bi-allelic MLH3 mutations. MSH3 and MLH3 germline heterozygotes had an increased risk of CRC (2.2-fold, p=6.6×10-5 and 1.6-fold, p=0.028, respectively), owing to somatic 'second hits' that inactivated the wildtype allele. Single second hits sometimes inactivated both MSH3 and the nearby APC gene. All CRCs with MSH3 or MLH3 deficiency were microsatellite-stable but hypermutant. Deletions of ≥2 bp were particularly increased (~12-fold) and signature ID4 was usually present (p<0.0001). CRCs from heterozygotes without 'second hits' showed no hypermutation. CONCLUSION: The phenotypes of bi-allelic MSH3 and MLH3 mutation carriers resemble some patients with cMMRd. Heterozygous germline MSH3 and MLH3 alleles have incomplete penetrance, but increase CRC risk via hypermutation, phenotypically resembling PMS2-mutant Lynch syndrome. A causal association with specific mutations has not previously been reported for ID4 in human tumours. ID4 probably does not have a single aetiology, but can result from MSH3 or MLH3 deficiency.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Soriano I, Sherwood K, Ward JC, et al. Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk. Gut. 2026. PMID: 42728028. doi:10.1136/gutjnl-2026-338390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。